Last 12 months
Inside the activity.
2 purchase rows · 107 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 2 | 3 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 26 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 9 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2019 Filed Mar 11, 2019 21:18 UTC |
WILSON JAMES NDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 105,782 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0000899243-19-007044 · doc4.xml · derivative · entry 4 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,218 Underlying: Common Stock · 105,782 shares Expires 2019-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 21:18 UTC |
WILSON JAMES NDirector
|
Exercise / conversionCommon Stock | 105,782 | $2.30 | $243,298.60 |
DisclosureSEC source: 0000899243-19-007044 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Mar 8, 2019 01:08 UTC |
WILSON JAMES NDirector
|
GiftCommon Stock | 13,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006768 · doc4.xml · nonDerivative · entry 1 WILSON JAMES N · CIK 0001236387 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust Disclosed balance after: 1,331,574 F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:34 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 70,000 | $11.39 | $797,097.00 |
DisclosureSEC source: 0001225208-19-002545 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,114,793 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.30 to $11.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:34 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 30,000 | $11.39 | $341,613.00 |
DisclosureSEC source: 0001225208-19-002545 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 996,838 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.30 to $11.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:41 UTC |
Maduck SeanSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000899243-19-003381 · doc4.xml · derivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:38 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 475,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000899243-19-003380 · doc4.xml · derivative · entry 1 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,000 Underlying: Common Stock · 475,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:36 UTC |
Robb Gary CharlesChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $11.35 | $0.00 |
DisclosureSEC source: 0000899243-19-003378 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023. Read SEC document |
| February 07, 2019 Filed Feb 13, 2019 02:44 UTC |
BRADBURY DANIELDirector
|
GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003384 · doc4.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BioBrit LLC Disclosed balance after: 130,575 Read SEC document |
| January 01, 2019 Filed Mar 5, 2020 22:59 UTC |
BAKER G LEONARD JRDirector
|
GiftCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-004449 · doc5.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,044,793 F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F1 · price: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC |
Robb Gary CharlesChief Financial Officer
|
GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 4 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC |
Robb Gary CharlesChief Financial Officer
|
GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 2,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC |
Robb Gary CharlesChief Financial Officer
|
GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 2,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 26, 2018 Filed Feb 11, 2019 22:53 UTC |
Robb Gary CharlesChief Financial Officer
|
GiftCommon Stock | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-003183 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 2,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| December 13, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · derivative · entry 9 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 10,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 13, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 10,000 | $2.24 | $22,400.00 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · nonDerivative · entry 4 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2018 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
OtherCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 4 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,000 F2 · kind: Transfer of shares without consideration to the Sean and Molly Maduck Living Trust. F3 · ownership.nature: Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee. Read SEC document |
| December 13, 2018 Filed Jun 3, 2025 00:57 UTC |
Maduck SeanSee Remarks
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080528 · ownership.xml · nonDerivative · entry 3 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,622 F1 · balance_after: Includes 458 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 265 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,009 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · derivative · entry 8 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,991 Underlying: Common Stock · 15,009 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 18, 2015, so that the total number of shares subject to this option becomes fully vested and exercisable on February 18, 2019. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 44,991 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · derivative · entry 7 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,009 Underlying: Common Stock · 44,991 shares Expires 2024-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
SaleCommon Stock | 60,000 | $19.01 | $1,140,366.00 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · nonDerivative · entry 3 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,024 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 15,009 | $3.29 | $49,379.61 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · nonDerivative · entry 2 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 01:12 UTC |
Maduck SeanSee Remarks
|
Exercise / conversionCommon Stock | 44,991 | $2.61 | $117,426.51 |
DisclosureSEC source: 0000899243-18-031133 · doc4.xml · nonDerivative · entry 1 Maduck Sean · CIK 0001698310 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:51 UTC |
Robb Gary CharlesChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0000899243-18-031129 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2023-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:51 UTC |
Robb Gary CharlesChief Financial Officer
|
SaleCommon Stock | 25,000 | $19.01 | $475,152.50 |
DisclosureSEC source: 0000899243-18-031129 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,858 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:51 UTC |
Robb Gary CharlesChief Financial Officer
|
Exercise / conversionCommon Stock | 25,000 | $1.92 | $48,000.00 |
DisclosureSEC source: 0000899243-18-031129 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:50 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 217,115 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0000899243-18-031128 · doc4.xml · derivative · entry 3 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,885 Underlying: Common Stock · 217,115 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:50 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
SaleCommon Stock | 217,115 | $19.01 | $4,126,509.40 |
DisclosureSEC source: 0000899243-18-031128 · doc4.xml · nonDerivative · entry 2 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,164,195 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| December 12, 2018 Filed Dec 15, 2018 00:50 UTC |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 217,115 | $1.19 | $258,366.85 |
DisclosureSEC source: 0000899243-18-031128 · doc4.xml · nonDerivative · entry 1 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Feb 13, 2019 02:41 UTC Amendment |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 217,115 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0000899243-19-003383 · doc4a.xml · derivative · entry 3 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,885 Underlying: Common Stock · 217,115 shares Expires 2019-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully exercisable. F3 · derivative.expiration_date: The transactions described herein were originally reported on a Form 4 filed on December 14, 2018. This Form 4 is hereby being amended to correct the stock option exercise date and it does not describe any additional transactions. Read SEC document |
| December 12, 2018 Filed Feb 13, 2019 02:41 UTC Amendment |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
SaleCommon Stock | 217,115 | $19.01 | $4,126,509.40 |
DisclosureSEC source: 0000899243-19-003383 · doc4a.xml · nonDerivative · entry 2 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,164,195 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $18.75 to $19.48 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| December 12, 2018 Filed Feb 13, 2019 02:41 UTC Amendment |
BELANOFF JOSEPH KDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 217,115 | $1.19 | $258,366.85 |
DisclosureSEC source: 0000899243-19-003383 · doc4a.xml · nonDerivative · entry 1 BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 22:13 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 70,000 | $12.73 | $890,785.00 |
DisclosureSEC source: 0001225208-18-015870 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 3,044,793 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 22:13 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 30,000 | $12.73 | $381,765.00 |
DisclosureSEC source: 0001225208-18-015870 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 966,838 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $12.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 22:26 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 25,420 | $12.87 | $327,104.56 |
DisclosureSEC source: 0001225208-18-015527 · doc4.xml · nonDerivative · entry 6 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 2,974,793 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.75 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 22:26 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 10,895 | $12.87 | $140,196.86 |
DisclosureSEC source: 0001225208-18-015527 · doc4.xml · nonDerivative · entry 3 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936,838 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.75 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 22:26 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 73,914 | $12.94 | $956,698.47 |
DisclosureSEC source: 0001225208-18-015527 · doc4.xml · nonDerivative · entry 5 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 2,949,373 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.72 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 22:26 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 31,677 | $12.94 | $410,008.08 |
DisclosureSEC source: 0001225208-18-015527 · doc4.xml · nonDerivative · entry 2 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 925,943 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.72 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 22:26 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 40,666 | $13.00 | $528,658.00 |
DisclosureSEC source: 0001225208-18-015527 · doc4.xml · nonDerivative · entry 4 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Ltd Partnership Disclosed balance after: 2,875,459 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 22:26 UTC |
BAKER G LEONARD JRDirector
|
PurchaseCommon Stock | 17,428 | $13.00 | $226,564.00 |
DisclosureSEC source: 0001225208-18-015527 · doc4.xml · nonDerivative · entry 1 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,266 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:06 UTC |
FISHMAN ROBERT SChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000899243-18-028605 · doc4.xml · derivative · entry 3 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,000 Underlying: Common Stock · 8,000 shares Expires 2025-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F3 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number at the first anniversary of September 28, 2015. Thereafter, 1/48th of the total number of shares subject to this option grant vests and becomes exercisable on each monthly anniversary, so that the total number of shares subject to this option becomes fully vested and exercisable on September 28, 2019. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:06 UTC |
FISHMAN ROBERT SChief Medical Officer
|
SaleCommon Stock | 8,000 | $13.74 | $109,887.20 |
DisclosureSEC source: 0000899243-18-028605 · doc4.xml · nonDerivative · entry 2 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $13.36 to $13.93 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:06 UTC |
FISHMAN ROBERT SChief Medical Officer
|
Exercise / conversionCommon Stock | 8,000 | $3.51 | $28,080.00 |
DisclosureSEC source: 0000899243-18-028605 · doc4.xml · nonDerivative · entry 1 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. Read SEC document |
| October 08, 2018 Filed Oct 9, 2018 21:11 UTC |
FISHMAN ROBERT SChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000899243-18-026440 · doc4.xml · derivative · entry 3 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,000 Underlying: Common Stock · 8,000 shares Expires 2025-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F3 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number at the first anniversary of September 28, 2015. Thereafter, 1/48th of the total number of shares subject to this option grant vests and becomes exercisable on each monthly anniversary, so that the total number of shares subject to this option becomes fully vested and exercisable on September 28, 2019. Read SEC document |
| October 08, 2018 Filed Oct 9, 2018 21:11 UTC |
FISHMAN ROBERT SChief Medical Officer
|
SaleCommon Stock | 8,000 | $13.19 | $105,537.60 |
DisclosureSEC source: 0000899243-18-026440 · doc4.xml · nonDerivative · entry 2 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $12.98 to $13.33 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| October 08, 2018 Filed Oct 9, 2018 21:11 UTC |
FISHMAN ROBERT SChief Medical Officer
|
Exercise / conversionCommon Stock | 8,000 | $3.51 | $28,080.00 |
DisclosureSEC source: 0000899243-18-026440 · doc4.xml · nonDerivative · entry 1 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 20:36 UTC |
FISHMAN ROBERT SChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000899243-18-024192 · doc4.xml · derivative · entry 3 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,000 Underlying: Common Stock · 8,000 shares Expires 2025-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F3 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number at the first anniversary of September 28, 2015. Thereafter, 1/48th of the total number of shares subject to this option grant vests and becomes exercisable on each monthly anniversary, so that the total number of shares subject to this option becomes fully vested and exercisable on September 28, 2019. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 20:36 UTC |
FISHMAN ROBERT SChief Medical Officer
|
SaleCommon Stock | 8,000 | $14.57 | $116,532.80 |
DisclosureSEC source: 0000899243-18-024192 · doc4.xml · nonDerivative · entry 2 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $14.22 to $14.81 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 20:36 UTC |
FISHMAN ROBERT SChief Medical Officer
|
Exercise / conversionCommon Stock | 8,000 | $3.51 | $28,080.00 |
DisclosureSEC source: 0000899243-18-024192 · doc4.xml · nonDerivative · entry 1 FISHMAN ROBERT S · CIK 0001232237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:54 UTC |
BAKER G LEONARD JRDirector
|
GrantStock Option (Right To Buy) · Derivative | 25,000 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0001225208-18-012868 · doc4.xml · derivative · entry 4 BAKER G LEONARD JR · CIK 0001201715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-08-20 F4 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.